JMDC Japan

Cancer Scan is a health research company focused on delivering healthcare data analysis, survey services, health screening, and disease management. It caters to research institutions, pharmaceutical companies, and government agencies, providing a range of services designed to enhance healthcare delivery. These services include promoting health screening, conducting healthcare data analysis, and facilitating disease management initiatives. By enabling collaboration among healthcare providers, Cancer Scan aims to improve medical services and outcomes for patients.

Antaa, Inc. is a Tokyo-based company that facilitates online connections among doctors to enhance medical treatment and decision-making. Founded in 2016, Antaa offers a platform that allows doctors to resolve questions collaboratively, share results from medical research, and access a learning environment created by and for medical professionals. The services include a question-and-answer feature, the dissemination of medical reports, and an archive of discussions, all designed to foster collaboration and provide second opinions within the medical community. Through these offerings, Antaa aims to improve the efficiency and effectiveness of medical practices.

Flixy Inc. is a Tokyo-based company that specializes in the development and sale of medical and healthcare software services. Founded in 2016, Flixy focuses on transforming the content of patient interviews into standardized medical terminology, thus enhancing communication and efficiency within healthcare settings. As of March 2020, Flixy operates as a subsidiary of JMDC Inc.

Heartseed Inc., founded in 2015 and located in Tokyo, Japan, focuses on developing myocardial regeneration medicine using induced pluripotent stem (iPS) cells. The company is dedicated to advancing the clinical application of regenerative medicine for heart disease, specifically through the development and commercialization of iPS cell-derived cardiomyocyte replacement therapy aimed at treating advanced heart failure. Heartseed's mission is to transform heart disease treatment by pioneering innovative solutions in myocardial regeneration.

Clintal Co., Ltd. is a Tokyo-based company that operates an online platform designed to facilitate healthcare consultations. Founded in 2015, Clintal provides users with access to detailed information about qualified medical professionals, enabling individuals to find the most suitable doctor for their needs. The platform allows users to diagnose symptoms and receive medical referrals through a chat application, which connects them with doctors based on their expertise and experience. By streamlining the process of identifying diseases and appropriate treatments, Clintal aims to enhance the overall healthcare experience for its users.